Back to top

Top Ranked Income Stocks to Buy for May 4th

Read MoreHide Full Article

Here are four stocks with buy rank and strong income characteristics for investors to consider today, May 4th:

AGNC Investment Corp. (AGNC - Free Report) : This real estate investment trusthas witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.9% over the last 60 days.

This Zacks Rank #2 (Buy) company has a dividend yield of 10.73%, compared with the industry average of 8.26%. Its five-year average dividend yield is 13.41%.

Caterpillar Inc. (CAT - Free Report) : This manufacturer of construction and mining equipmenthas witnessed the Zacks Consensus Estimate for its current year earnings jumping 31.9% over the last 60 days.

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 3.03%, compared with the industry average of 0.78%. Its five-year average dividend yield is 3.09%.

Eastman Chemical Company (EMN - Free Report) : This manufacturer of specialty additives, chemicals, and fibershas witnessed the Zacks Consensus Estimate for its current year earnings advancing 2.2% over the last 60 days.

This Zacks Rank #2 (Buy) company has a dividend yield of 2.60%, compared with the industry average of 0.76%. Its five-year average dividend yield is 2.06%.

Methanex Corporation (MEOH - Free Report) : This methanol producing company has witnessed the Zacks Consensus Estimate for its current year earnings jumping more than 100% over the last 60 days.

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 2.50%, compared with the industry average of 0.76%. Its five-year average dividend yield is 2.27%.

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>



More from Zacks Zacks #1 Rank Additions

You May Like